(Q46121480)

19 December 2017

editorial

0 references

title

The vaptans ante portas: a status report (English)

1 reference

19 December 2017

author name string

Peter Gross

series ordinal

1

1 reference

19 December 2017

Tadeusz Marczewski

series ordinal

2

1 reference

19 December 2017

Kay Herbrig

series ordinal

3

1 reference

19 December 2017

language of work or name

English

0 references

publication date

13 February 2009

1 reference

19 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

1371-1373

1 reference

19 December 2017

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

Medical costs of abnormal serum sodium levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

21 January 2018

Refractory hyponatremia

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

Nephrogenic syndrome of inappropriate antidiuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

Increased renal responsiveness to vasopressin and enhanced V2 receptor signaling in RGS2-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP034

21 January 2018

Identifiers

DOI

10.1093/NDT/GFP034

1 reference

19 December 2017

1 reference

19 December 2017